bioRxivNeurosciencePreprint
Comparison of cerebrospinal fluid biomarkers relevant to neurodegenerative diseases in healthy cynomolgus and rhesus macaque monkeys
Emma L. Robertson, Susan E. BoehnkeiD, Natalia M. Lyra e SilvaiD, Brittney Armitage‐Brown, Andrew WinterborniD, Douglas J. CookiD, Fernanda G. De FeliceiD, Douglas P. MunoziD
Abstract
Structured AbstractO_ST_ABSINTRODUCTIONC_ST_ABSNon-human primates are important translational models of neurodegenerative disease. We characterized how species, sex, age, and site of sampling affected concentrations of key biomarkers of neurodegeneration. METHODSAmyloid-beta (A{beta}40, A{beta}42), tau (tTau, pTau), and neurofilament light (NFL) in CSF were measured in 82 laboratory-housed naive cynomolgus and rhesus macaques of both sexes. RESULTSA{beta}40, A{beta}42, and NFL were significantly higher in rhesus compared with cynomolgus macaques. tTau and NFL were higher in males. pTau was not affected by species or sex. Site of acquisition only affected NFL, with NFL being higher in CSF acquired from lumbar compared with cisterna magna puncture. DISCUSSIONNormative values for key neurodegeneration biomarkers were established for laboratory housed cynomolgus and rhesus macaque monkeys. Differences were observed as a function of species, sex and site of CSF acquisition that should be considered when employing primate models. Research In ContextO_LISystematic review: We reviewed reports characterizing CSF biomarkers of neurodegenerative diseases in non-human primates - an increasingly important model of disease - revealing that studies with laboratory housed macaque monkeys were of small sample size, with a paucity of data about how biomarkers varied as a function of species, sex, age, and site of acquisition. C_LIO_LIInterpretation: To address this gap, we collected CSF from 82 naive laboratory housed male and female macaques of two species and measured A{beta}40, A{beta}42, tTau, pTau, and NFL. In addition to providing normative statistics for concentrations of these biomarkers, we revealed various species and sex differences. C_LIO_LIFuture directions: Establishing normative values of biomarkers is an important step to the efficient development of cynomolgus and rhesus macaques as models of neurodegenerative disorders such as Alzheimers disease. Reference values reduce the need for large control groups by which to compare with disease model animals. C_LI
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Comparative Study of Plasma Biomarkers of Neurodegeneration in Rhesus Monkeys (Macaca mulatta) and Baboons (Papio anubis)
Michele Marie Mulholland, Elizabeth R. Magden, … William Donald Hopkins·bioRxiv·Jul 8, 2026
- Expression patterns of blood-based biomarkers of neurodegeneration and inflammation across adulthood in rhesus macaques
Ludwig A. P. Metzler, Jeanette M. Metzger, … Amita Kapoor·Experimental GerontologyPeer-reviewed·Mar 21, 2025
- Clinically Relevant Biomarkers of Alzheimers Disease Are Associated with Age and Cortical Atrophy in Chimpanzees (Pan troglodytes)
Michele Marie Mulholland, Elizabeth R. Magden, … William Donald Hopkins·bioRxiv·Aug 20, 2026
- Quantitative analysis of synaptic pathology and neuroinflammation: an initial study in a female rhesus monkey model of the “synaptic” phase of Alzheimer’s disease
Danielle Beckman, Kristine Donis‐Cox, … John H. Morrison·bioRxiv·Jan 19, 2018
- Fluid amyloid-β (Aβ) biomarkers reflect early β-sheet-rich Aβ deposition during the preclinical stage in Alzheimer's disease model 5XFAD mice
Hiroko Yagihara, 齋藤 祐幸, … Eiko Nakano Minakawa·Experimental NeurologyPeer-reviewed·Oct 1, 2026
- African Green Monkeys Respond to Synthetic AB Oligomers with Persistent Alzheimers-like Activation
Bianca R. P. Brown, Xiaoting Li, … Andrew D. Miranker·bioRxiv·Oct 8, 2025